GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » 12-1 Month Momentum %

Orexo AB (OSTO:ORX) 12-1 Month Momentum % : 46.80% (As of May. 05, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Orexo AB 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-05), Orexo AB's 12-1 Month Momentum % is 46.80%.

The industry rank for Orexo AB's 12-1 Month Momentum % or its related term are showing as below:

OSTO:ORX's 12-1 Month Momentum % is ranked better than
83.06% of 1116 companies
in the Drug Manufacturers industry
Industry Median: -6.64 vs OSTO:ORX: 46.80

Competitive Comparison of Orexo AB's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orexo AB's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Orexo AB's 12-1 Month Momentum % falls into.



Orexo AB  (OSTO:ORX) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orexo AB  (OSTO:ORX) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Orexo AB 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Orexo AB's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orexo AB (OSTO:ORX) Business Description

Traded in Other Exchanges
Address
Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105
Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments US Pharma, Digital Therapeutics (DTx) and HQ & Pipeline. The majority is from the US Pharma segment. Geographically, the majority is derived from the United States. US Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline include the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB (OSTO:ORX) Headlines

No Headlines